AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 141 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $98,000 | +50.8% | 8,483 | +30.8% | 0.00% | +100.0% |
| Q2 2019 | $65,000 | +1.6% | 6,483 | +30.1% | 0.00% | -33.3% |
| Q1 2019 | $64,000 | -15.8% | 4,983 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $76,000 | -24.0% | 4,983 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $100,000 | +3.1% | 4,983 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $97,000 | -3.0% | 4,983 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $100,000 | +72.4% | 4,983 | +13.7% | 0.00% | +100.0% |
| Q4 2017 | $58,000 | -6.5% | 4,383 | +29.6% | 0.00% | -33.3% |
| Q3 2017 | $62,000 | +34.8% | 3,383 | +35.5% | 0.00% | +50.0% |
| Q2 2017 | $46,000 | +70.4% | 2,496 | +108.0% | 0.00% | +100.0% |
| Q1 2017 | $27,000 | -28.9% | 1,200 | +9.1% | 0.00% | -50.0% |
| Q4 2016 | $38,000 | +40.7% | 1,100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $27,000 | -98.9% | 1,100 | -99.4% | 0.00% | -94.7% |
| Q2 2016 | $2,401,000 | +2792.8% | 192,420 | +5358.7% | 0.04% | +3700.0% |
| Q1 2016 | $83,000 | – | 3,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
| Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
| Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
| Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
| Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |